Issue 36, 2024

Investigation of pantoprazole loading and release from a magnetic-coated chitosan-modified zirconium-based metal–organic framework (MOF) as a nanocarrier in targeted drug delivery systems

Abstract

This study reports a novel magnetic and porous nanocomposite, Fe3O4@CS@UIO-66-NH2(Zr), developed by growing a zirconium-based metal–organic framework on magnetite–chitosan. It is designed for targeted and delayed pantoprazole delivery, the nanocomposite exhibits pH-sensitive behavior and functions as an efficient nanocarrier. The synthesis process involved coating magnetite nanoparticles with chitosan, followed by the growth of UIO-66-NH2(Zr) on the coated nanoparticles. The nanocomposite demonstrated high drug loading efficiency (DLE) in acetate buffer (pH 5.0) and deionized water, with loading percentages of 79% and 75%, respectively, within 48 hours. The corresponding drug loading content (DLC) was approximately 14% and 10%. The Freundlich and Langmuir models accurately described the multilayer adsorption behavior of pantoprazole on the nanocomposite's active sites. BET and EDX-map analyses confirmed that the drug was loaded into the nanocomposite's pores and uniformly adsorbed on its surface. The drug release kinetics were best described by the pseudo-second-order model. Due to its porosity, magnetic properties, and favorable drug loading characteristics, the Fe3O4@CS@UIO-66-NH2(Zr) nanocomposite shows potential as an efficient targeted drug delivery system for in vivo applications.

Graphical abstract: Investigation of pantoprazole loading and release from a magnetic-coated chitosan-modified zirconium-based metal–organic framework (MOF) as a nanocarrier in targeted drug delivery systems

Article information

Article type
Paper
Submitted
14 Jun 2024
Accepted
07 Aug 2024
First published
19 Aug 2024
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2024,14, 26091-26102

Investigation of pantoprazole loading and release from a magnetic-coated chitosan-modified zirconium-based metal–organic framework (MOF) as a nanocarrier in targeted drug delivery systems

A. Yaghoubian, M. Setoodehkhah and F. Parsa, RSC Adv., 2024, 14, 26091 DOI: 10.1039/D4RA04365K

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements